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ABSTRACT
The mouse gene for the natural killer (NK) cell-
activating receptor Nkg2d produces two protein
isoforms, NKG2D-S and NKG2D-L, which differ by
13 amino acids at the N-terminus and have different
signalling capabilities. These two isoforms are pro-
duced through differential splicing, but their regula-
tion has not been investigated. In this study, we
show that rat Nkg2d has the same splicing pattern
as that of the mouse, and we mapped transcrip-
tional start sites in both species. We found that
the splice forms arise from alternative promoters
and that the NKG2D-L promoter is derived from a
rodent B1 retrotransposon that inserted before
mouse–rat divergence. This B1 insertion is asso-
ciated with loss of a nearby splice acceptor site
that subsequently allowed creation of the short
NKG2D isoform found in mouse but not human.
Transient reporter assays indicate that the B1
element is a strong promoter with no inherent
lymphoid tissue-specificity. We have also identified
different binding sites for the ETS family member
GABP within both the mouse and rat B1 elements
that are necessary for high-promoter activity and
for full Nkg2d-L expression. These findings demon-
strate that a retroelement insertion has led to gene-
regulatory change and functional diversification of
rodent NKG2D.
INTRODUCTION
The activity of natural killer (NK) cells against potential
target cells is regulated by a balance of inhibitory and
activating receptors (1–3). One of the most well-studied
activating receptors is NKG2D, which recognizes ligands
often upregulated in response to stress, such as during
virus infection or malignant transformation (4). A recent
study using NKG2D deﬁcient mice has demonstrated that
expression of this receptor inhibits some types of cancer
in spontaneous tumour models (5), indicating a signiﬁcant
role for NKG2D in tumour surveillance. The importance
of NKG2D is also indicated by the existence of speciﬁc
viral evasion mechanisms directed against it (6).
In the mouse, NKG2D is expressed on NK cells, acti-
vated CD8
+ T cells, NKT cells, gdT cells and activated
macrophages (7). Alternative splicing produces two diﬀer-
ent isoforms of NKG2D in mouse, one of which contains
13 extra amino acids at its N terminus (NKG2D-L) com-
pared to the shorter isoform (NKG2D-S) (8). NKG2D-S
can bind and signal through the adapters DAP10 and
DAP12, while NKG2D-L can only bind DAP10 (8).
Due to diﬀerential downstream pathways, DAP12 is
capable of initiating cytotoxic as well as cytokine
release responses while DAP10 can only activate an NK
cell to kill (9). CD8
+ T cells express only DAP10,
whereas NK cells express both DAP10 and DAP12 (8).
Resting mouse NK cells express very little NKG2D-S,
but expression of this isoform is induced upon NK cell
activation, enabling signalling through NKG2D-L/
DAP10, NKG2D-S/DAP10 and NKG2D-S/DAP12 (8).
These expression patterns of DAP10/12 and of mouse
NKG2D isoforms result in functional diversiﬁcation of
this receptor. In mouse NK cells, NKG2D is strongly
activatory, stimulating NK cells to attack bound targets.
However, in CD8
+ T cells, NKG2D serves only a
co-stimulatory function (10). The situation in human is
slightly diﬀerent. The single human NKG2D isoform
resembles mouse NKG2D-L and also only binds DAP10
(11–13). Not surprisingly, NKG2D stimulation using
monoclonal antibodies in human NK cells initiates a
cytotoxic response but not cytokine release (13). As in
the mouse, NKG2D/DAP10 only acts in a co-stimulatory
manner in human CD8
+ T cells (14).
While many studies have concentrated on the func-
tion of NKG2D, surprisingly little is known about
its transcriptional regulation. Here we show that the
spliced isoforms of mouse NKG2D arise from the use of
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mouse NKG2D-L and show it to be derived from a
rodent-speciﬁc B1 retrotransposon with a functional
binding site for GABP, a member of the ETS family.
We propose that insertion of this retrotransposon,
through unusual donation of a polymerase II promoter,
led to the alternative splicing patterns maintained in
both mouse and rat that, in turn, result in functionally
distinct NKG2D isoforms. These results document an
intriguing example of how retrotransposons can aﬀect
the evolution of host gene expression and, more speciﬁ-
cally, lend insight into the transcriptional regulation of
NKG2D.
MATERIALS AND METHODS
Cell culture
LNK (mouse NK cell line), EL4 (mouse T cell line) and
RNK16 (rat NK cell line) were cultured in RPMI 1640
medium supplemented with 10% (v/v) fetal bovine serum,
100U/ml penicillin, 100U/ml streptomycin, 50mM 2-ME
and 2mM L-glutamine. LNK cells were further supple-
mented with 1000U/ml IL-2 (Peprotech). NIH 3T3
(mouse embryonic ﬁbroblast cell line) was cultured in
Dulbecco’s modiﬁed Eagle’s medium supplemented with
10% fetal calf serum.
Mice
C57BL/6 (B6) mice were purchased from The Jackson
Laboratory and bred in our animal facility. The use
of animals for this study was approved by the Animal
Care Committee of the University of British Columbia,
and animals were maintained in accordance with the
guidelines of the Canadian Council on Animal Care.
Reverse-transcriptase polymerase chain (RT–PCR)
reaction and sequencing
All RT–PCR was performed using Superscript III
(Invitrogen) using random primers according to manufac-
turer’s instructions. For Sprague–Dawley rat total RNA
(Clonetech), PCR was then carried out using gene-speciﬁc
primers: rat exon 1a forward, 50-GATTCACAAGAAAC
AGGACCTC; rat exon 1b forward, 50-TGGCATGGGTT
CGTGATC; rat exon 4 reverse, 50-CAACAAGGACTCG
AACAACG. PCR products were cloned into pGEMT
vector (Promega) according to manufacturer’s instruc-
tions. Sequencing was performed using the T7 primer by
McGill University and Genome Que ´ bec Innovation
Centre Sequencing Platform. For LNK, RNK16, EL4
and NIH 3T3 cell lines, total RNA was collected using
Rneasy minikit and QIAshredder homogenizer
(QIAGEN). The RNA samples were treated with DNase
I twice: during puriﬁcation using the on-column protocol
of the Rneasy minikit and after elution using DNase I
from Invitrogen. PCR primers used were as follows:
mouse exon 1a forward, 50-GAAACAGGATCTCCCTT
CTCT; mouse exon 1b forward, 50-ACAACCTGGATCA
GTTTCTGAA; mouse exon 6 reverse, 50-GGTTCCAGG
TTTTCTCTTCATT; rat exon 1a forward, 50-GATTCAC
AAGAAACAGGACCTC; rat exon 1b forward, 50-TGG
CATGGGTTCGTGATC; rat exon 6 reverse, 50-GGTTC
CAGGCTTTGTTCTCA; GAPDH forward, 50-GTGGA
GTCTACTGGTGTCTTC; GAPDH reverse, 50-GTGGC
AGTGATGGCATGGAC.
Sequencealignment
Nucleotides positioned from  75 to +75 from the splice
acceptor site of human NKG2D exon 2 were used as the
reference sequence in UCSC Genome browser (http://gen
ome.ucsc.edu). From the conservation tract, the ortholo-
gous sequences of rhesus, mouse, rat, guinea pig, hedge-
hog, horse, cow and armadillo were obtained. These
sequences were aligned using Multiple Alignment using
Fast Fourier Transform and G-INS-i strategy (MAFFT,
http://align.bmr.kyushu-u.ac.jp/maﬀt/online/server/index.
html). The same was done for  50 to +50 of the ATG in
human exon 3 and for aligning PB1D9 with B1Mur3.
5’RACE
C57BL/6 mouse spleens were homogenized. Total RNA
was extracted from LNK cells and mouse splenocytes
using Rneasy minikit and QIAshredder homogenizer
(QIAGEN). Sprague–Dawley rat total RNA was pur-
chased from Clonetech. 50RACE was performed using
FirstChoice RLM-RACE kit (Ambion) according to
manufacturer’s instructions. The primers used were as fol-
lows: mouse exon 6 reverse ﬂanking, 50-GGTTCCAGGT
TTTCTCTTCATT; mouse exon 6 reverse nested, 50-TT
GTTCTGTGACATATCCAGTT; rat reverse exon 6
ﬂanking, 50-GGTTCCAGGCTTTGTTCTCA; rat reverse
exon 4 nested, 50-CAACAAGGACTCGAACAACG.
Generationof luciferase reporter constructs
Promoter fragments were generated by PCR using for-
ward primers with KpnI site inserted at the 50 end and
reverse primers with NheI site inserted at the 50 end.
PCR products were digested with KpnI/NheI (NEB) and
cloned into pLG4.10 ﬁreﬂy luciferase promoter vector
(Promega). The only exception is the generation of a
construct containing the mouse B1 and a 391-bp fragment
at separate sites. For this construct, the mouse B1 was
cloned into the multiple cloning region using KpnI/NheI
while the 391bp fragment was inserted into a BamHI
site downstream of the luciferase reporter gene. The pri-
mers used are as follows: mouse B1 forward: 50-AAGG
TACCCGGAAGTGGTGTCACATA; mouse B1 reverse:
50-AAGCTAGCTTTTTTAAGACAGTGTATC; mouse
 391 of B1 forward: 50-AAGGTACCCTGACATTTAT
TTATCTT; mouse  1 of B1 reverse: 50-AAGCTAGCA
ATCTGTCCTAATTTCTG; mouse 391-bp BamHI
forward: 50-AAGGATCCCTGACATTTATTTATCTT;
mouse 391-bp BamHI reverse: 50-AAGGATCCAATCT
GTCCTAATTTCTG; rat B1 forward: 50-AAGGTACC
AACCAGAAGCAGTGTCACC; rat B1 reverse: 50-AA
GCTAGCTTTCTAAAGACAGTTTGTCTCTCT; B1 30
32-bp truncation reverse: 50-AAGCTAGCGGCTACCTC
AGATTTACAG; B1 30 59-bp truncation reverse: 50-AA
GCTAGCTGCCTCTGCTTCCTGAATG. The PB1D9
fragment truncated 20bp at the 50 end and 59bp at the
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nucleotides, digesting with KpnI/NheI, and ligating
into pGL4.10. The oligonucleotide sequences were as
follows: 50-AAGGTACCTTTAATCTCAGCATTCAGG
AAGCAGAGGCAGCTAGCAA and 50-TTGCTAGCT
GCCTCTGCTTCCTGAATGCTGAGATTAAAGGTA
CCTT. One microgram of each oligonucleotide was mixed
in 20ml of water and heated to 958C and then allowed
to cool to room temperature. Primers used to clone
GABP and AP1 mutants were as follows: GABP mutant
forward: 50-AAGGTACCCGTTAGTGGTGTCACATA
(mutation is underlined); AP1 mutant forward: 50-AAG
GTACCCGGAAGTGGTGGCACATA; double mutant
forward: 50-AAGGTACCCGTTAGTGGTGGCACATA.
Celltransfection and luciferase assays
LNK, EL4 and NIH 3T3 cells were transfected using
Lipofectamine 2000 (Invitrogen) according to manufac-
turer’s instructions. Brieﬂy, 2.5 10
6 LNK and EL4 cells
and 6 10
5 NIH 3T3 cells were seeded into 500mlo f
growth media in 24-well plates for 24h at 378C. For
each well, transfection media was prepared: 2mlo f
Lipofectamine 2000 reagent was mixed with 1mgo f
DNA for LNK and EL4 while 0.5ml of Lipofectamine
2000 reagent was mixed with 0.6mg of DNA for NIH
3T3. Transfection media was brought up to 100ml using
unsupplemented media and incubated at 378C for 20min.
Next, growth media in each well was exchanged with
150ml of unsupplemented media and 100ml of transfection
media. Cells were incubated at 378C for 6h before being
topped up with 250ml of media supplemented with 20%
fetal bovine serum or fetal calf serum and IL-2 where
necessary. Cells were then incubated at 378C for 16h
before assaying.
Luciferase activity was assayed using the Dual-
Luciferase Reporter Assay System (Promega) according
to the manufacturer’s instructions. Fireﬂy luciferase
activity was normalized relative to Renilla luciferase
activity for each transfection and calculated as fold
increase over pGL4.10-BASIC (pGL4B).
Electrophoretic mobility shift assays (EMSAs)
Double stranded probes were generated by annealing
the following oligomers to their complementary oligo-
mers: mouse wild type: 50-AGGACAGATTCGGAAGT
GGTGTCACATATCTTTA; mouse GABP mutant: 50-A
GGACAGATTCGTTAGTGGTGTCACATATCTTTA;
mouse AP1 mutant: 50-AGGACAGATTCGGAAGTGG
TGGCACATATCTTTA; mouse double mutant: 50-A
GGACAGATTCGTTAGTGGTGGCACATATCTTTA;
rat GABP1 wild type: 50-GAGCCTGAACCAGAAGC
AGTGTCACCTA; rat GABP1 mutant: 50-GAGCCTG
AACCATTAGCAGTGTCACCTA; rat GABP2 wild
type: 50-TGGTCTATACAGGAAGTTCTAAGATATC;
rat GABP2 mutant: 50-TGGTCTATACAGTTAGTT
CTAAGATATC. Nuclear extraction, probe labelling
and the gel-shift assay were preformed as described
before (15). Protein concentration was determined
using the Qubit Quantitation Platform (Invitrogen).
GABPa antibody (H-2 X) and c-Jun antibody (G-4 X)
were purchased from Santa Cruz Biotechnology.
siRNA andreal-time RT–PCR
LNK cells (5 10
4 per well) were seeded in 96-well plates
and grown overnight in 100ml serum-free RPMI 1640
medium supplemented with 1000U/ml IL-2. The next
day, the growth media was removed, and cells were trans-
fected with 1mM Accell SMARTpool mouse GABPA
siRNA or Accell Non-Targeting Pool siRNA using
100ml Accell siRNA Delivery media (Dharmacon) supple-
mented with 1000U/ml IL-2. An untreated sample was
also included where the media was exchanged, but no
siRNA was added. Seventy-two hours later, total RNA
collection and RT–PCR were carried out as described
above. Three wells were pooled per treatment. The
resultant cDNA was used as template in real-time
PCR using the 7500 Fast Real-Time PCR System
(Applied Biosystems). Relative expression was determined
using the 2
 CT method. Threshold cycles for Gabp,
Nkg2d-S and Nkg2d-L were normalized to Gapdh.
Primers used were GAPDH forward: 50-GACTTCAAC
AGCAACTCCCAC; GAPDH reverse: 50-TCCACCAC
CCTGTTGCTGTA; NKG2D-S forward: 50-GAAGGC
TTTGACTCACAAGAAACAGG; NKG2D-L forward:
50-TGGCATTGATTCGTGATCGAAAGTCT; NKG2D
reverse: 50-CTCCAGGTTGACTGGTAGTTAGTGC.
RESULTS
A rodent SINEelement is linked to alternative exon 1usage
To begin to dissect the transcriptional regulation of mouse
NKG2D, we ﬁrst examined the mouse Nkg2d sequence via
the UCSC Genome browser (http://genome.ucsc.edu) and
noticed a repetitive B1 element, termed PB1D9, inserted at
the 30 end of intron 1. An orthologous SINE element is
found in the rat (termed B1Mur3) but not in the human,
NKG2D gene. The two B1 elements diﬀer by a 50 3-bp
deletion in the mouse B1 and an internal 30-bp insertion
in the rat B1, but are otherwise 84.4% identical (aligned
using MAFFT, http://align.bmr.kyushu-u.ac.jp/maﬀt/
online/server/index.html). Although annotated diﬀerently
in mouse and rat by Repbase (http://www.girinst.org/
repbase/index.html), these B1 elements represent the
same ancestral insertion. To avoid confusion, we will
refer to the mouse element as mB1 and the rat element
as rB1. While there are two mouse NKG2D isoforms
arising from transcripts that alternatively encode exon
1a or 1b, there is only one human NKG2D protein from
transcripts that always include exon 2, which is homo-
logous to mouse exon 1b (Figure 1A). The situation in
rat is less clear. A rat mRNA initiating near the region
homologous to mouse exon 1b has been previously
described (16). However, a rat genomic sequence that is
highly similar to mouse exon 1a is found upstream of
this initiation exon (Figure 1A). To see if rat Nkg2d
splicing patterns resemble those of the mouse, we under-
took RT–PCR on Sprague–Dawley rat splenic total RNA.
Primers were designed in rat sequences orthologous to
mouse exons 1a and 4. Sequencing of the ampliﬁed
3034 Nucleic Acids Research, 2009, Vol. 37,No. 9product shows that a rat transcript indeed includes
the region orthologous to mouse exon 1a and splices
out the previously reported exon (Figure 1B). Further-
more, the splice sites used are the same as that of the
mouse. We herein designate the exon found by RT–PCR
as rat exon 1a and the alternative exon as rat exon 1b.
As was done with the mouse (8), we also designate the
isoform arising from exon 1a as rNKG2D-S and the
isoform arising from exon 1b as rNKG2D-L. These
results suggest that the Nkg2d splicing pattern in rat is
identical to that of the mouse and that both species
harbour a SINE element at the 30 end of intron 1. In com-
parison, human does not have the SINE element and
splicing of NKG2D always gives rise to one protein.
The SINE element has polymerase IIpromoter potential
To determine if the SINE element is contributing an
alternative promoter element, we ﬁrst looked for tran-
scription start sites (TSS) for mouse and rat NKG2D-L
transcripts using 50 rapid ampliﬁcation of cDNA ends
(50RACE). Primers were designed in mouse exon 6
and rat exons 4 and 6. We found two start sites within
the mB1 element using C57BL/6 splenocytes (Figure 2A).
Two additional sites were found using LNK, a mouse
NK cell line that expresses both NKG2D isoforms
(Figure 2B). Surprisingly, while one was located in the
SINE element, the other lies downstream of the ATG1
start codon. Theoretically, this transcript could still be
translated into NKG2D-S using the ATG2 start codon
in exon 2. Further experiments are needed to verify
this possibility. With RNA from Sprague–Dawley rat
spleen, we found a dispersed pattern of TSS (Figure 2C).
Two start sites were within the rB1 element while seven
were downstream of the SINE but upstream of ATG1.
The 50RACE experiments suggest that the rodent SINE
element contains a functional promoter. To examine this
possibility, we tested the mouse and rat SINE elements
and the upstream region in luciferase reporter assays.
Various fragments including and excluding mB1 and rB1
were cloned into pGL4B. These constructs were transi-
ently transfected into LNK cells and promoter activity
was measured. As shown in Figure 2D, both mB1 and
rB1 elements by themselves display promoter activity.
A fragment 391-bp upstream of mB1 shows no apprecia-
ble activity. Paradoxically, when this upstream region
combined with mB1 was tested, the promoter activity
was abolished. However, if this fragment was separated
from mB1 in the same construct, only a small decrease
in promoter activity was observed compared to a con-
struct with mB1 alone. These results demonstrate that
transcription not only starts within the SINE elements,
but also that they contain polymerase II promoters.
The mouse B1element contributes afunctional
GABP-binding site
Transposable elements harbouring functional enhancer
sites are not uncommon (17). Thus, we interrogated
the mouse mB1 sequence for potential transcription
factor-binding sites using TESS (http://www.cbil.upenn.
edu/cgi-bin/tess/tess). Curated results containing only
mouse-speciﬁc, hematopoietic or lymphocyte-related
transcription factors are shown in Figure 3A. To deter-
mine which of these sites contribute functional regulatory
elements, luciferase reporter assays were carried out
using truncated fragments of mB1 in pGL4B, transiently
transfected in LNK cells. Surprisingly, fragments that
truncate the 30 end of mB1 display much higher activity
than the entire 109-bp mB1 (Figures 2D and 3B). A 77-bp
fragment that eliminates the predicted TCF1, CEBPb
and YY1-binding sites at the 30 end shows 40-fold activity
over basal. Of note, this piece removes an ATG at the
+78 position. When the 77-bp segment was further 30
truncated to 50bp, eliminating two more TCF1 and one
GATA3 binding site, 97-fold activity over basal was
observed. Luciferase activity only dropped to 3-fold over
basal when 20bp were deleted at the 50 end of the 50-bp
segment. This construct deletes a GABP, an AP1 and a
GATA3-binding site. These results suggest that the essen-
tial transcription factor-binding sites are within the ﬁrst
20bp of mB1.
To further narrow down the essential transcription
factor-binding sites, we mutated the potential GABP
and AP1-binding sites and repeated the reporter assays
in LNK cells. We chose to mutate the 77-bp construct,
because the ATG at position +78 may be interfering
with luciferase expression. Promoter activity does not
Figure 1. NKG2D genomic organization and splicing pattern. (A)A
comparison of NKG2D exon–intron organization and splice variants
in human, mouse and rat. Human exon nomenclature was revised
based on 50RACE from another study (13). Exons are labelled with
roman numerals. Translated regions are shown as thicker solid boxes.
Open boxes indicate the B1 element present in mouse and rat. Rat exon
1a was previously uncharacterized, and hence the ﬁrst intron is shown
as dotted line. (B) RT–PCR detection of an Nkg2d-S transcript in rat.
Total RNA from Sprague–Dawley rat was used for reverse transcrip-
tase reactions. Primers used for PCR are marked by arrows. PCR
product was sequenced and shown as spliced transcript in the diagram.
Nucleic Acids Research,2009, Vol.37, No. 9 3035decrease appreciably using an AP1 mutant construct
(Figure 3B). On the other hand, the GABP mutant and
double mutant only show 2- and 4-fold activity over basal,
respectively. These results indicate that the GABP-binding
site is essential to enhancing transcription from the mB1
polymerase II promoter.
GABP binds the identified mB1 enhancer site invitro
The core GGAA nucleotides in the binding sites of ETS
family members, of which GABP is a member, are highly
conserved. To determine if GABP is indeed binding to this
mB1 element, EMSA were performed. When a DNA oli-
gomer spanning the 50 end of mB1 was incubated with
LNK nuclear extracts, two complexes are clearly visible
in EMSAs, labelled I and II (Figure 4). Complex I con-
tains GABP, since it can be supershifted by anti-GABPa
antibody. This complex is decreased or abolished using
wild-type unlabelled oligomers in a dose-dependent
manner (10-, 25-, 50- and 100-fold excess). Complex I is
still clearly visible when unlabelled oligomers containing a
mutated GABP site or with mutations in both the GABP
and AP1 sites were used as competitors. The fact that
these signals are lower compared to complex I without
competitors is likely the result of non-speciﬁc competition
at 100-fold excess. In agreement with the previous experi-
ments, the oligomer did not seem to bind AP1. A compe-
tition assay using unlabelled oligomers with a mutated
AP1 site did not produce any complexes. In addition,
anti-AP1 antibody did not induce a supershift. The iden-
tity of complex II is currently unknown. It is possible that
this complex contains GATA3, since the oligomer spans a
GATA3-binding site. Furthermore, all mutant competi-
tors were equally eﬀective at abolishing this complex
and neither anti-GABP nor anti-AP1 antibodies super-
shifted the complex. Taken together, these results suggest
that GABP, but not AP1, is an important factor in tran-
scription from mB1.
GABP binds aseparate site in ratB1in vitro
We wondered if GABP regulation of the B1 promoter is
conserved between mouse and rat. An alignment of mB1
Figure 2. Detection of polymerase II promoter in SINE elements. (A)
RLM-50RACE of mouse Nkg2d. Sequence shown corresponds to
chr6:129572548–29572772 of the mouse genome from UCSC
Genome Browser (mm9 assembly). Underlined sequence represents
the mB1 element inserted in front of exon 1b. Single stars mark tran-
scription start sites found in C57BL/6 mouse spleen. Stacked double
stars mark transcription start sites found in LNK mouse cell line.
ATG1 start codon for mNKG2D-L is in brackets. Splice donor site
of exon 1b is denoted with an arrow. (B) Detection of Nkg2d splice
forms in LNK, RNK16, EL4 and NIH 3T3 cell lines with RT–PCR.
The mouse exon–intron structure of Nkg2d is shown with exons
labelled in roman numerals. Primers used are shown as arrowheads.
(C)5 0RACE of rat Nkg2d. Sequence shown corresponds to
chr4:166923873–166924142 of the rat genome from UCSC Genome
Browser (rn4 assembly). Single stars mark transcription start sites
found in Sprague–Dawley rat spleen. Underlined sequence represents
the rB1 element. ATG1 start codon for rNKG2D-L is in brackets.
Splice donor site of exon 1b is denoted with an arrow. (D) Luciferase
reporter assay of SINE elements. Fragments including the rodent
SINEs and 391-bp upstream of the mouse SINE were cloned into
pGL4B and assayed using a dual-luciferase system. Promoter activity
was normalized to co-transfected Renilla luciferase activity and calcu-
lated as fold above pGL4B. Data indicate mean ( SD) of three inde-
pendent experiments.
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of the core GGAA sequence at the mB1 GABP-binding
site (Figure 5A). However, a separate potential GABP-
binding site is found in the internal insertion of rB1
using TESS (http://www.cbil.upenn.edu/cgi-bin/tess/tess).
These sites in rB1 were labelled GABP1 and GABP2,
respectively. To see if either of these sites bind rat
GABP, we subjected them to EMSA. DNA oligomers
containing GABP2, but not GABP1, formed DNA–
protein interactions with RNK16 (an Nkg2d expressing
rat NK cell line, Figure 2B) nuclear extract (Figure 5B).
The identity of the protein in this sole complex, labelled
III, was conﬁrmed to be GABP in a supershift assay
using an anti-GABPa antibody. Complex III can be abol-
ished using wild-type unlabelled oligomers at 100-fold
excess but not with oligomers where the GABP2 site is
mutated. These results suggest that GABP also regulates
transcription from the rB1 promoter but uses a diﬀerent
binding site compared to mB1.
GABP isrequired forfull NKG2D-L expression invivo
To show that GABP is involved in the transcription of the
natural Nkg2d locus, we adopted an RNAi strategy. We
examined the eﬀects of transient siRNA knockdown
Figure 4. GABP forms protein–DNA complex within mB1 in EMSA.
Sequences of probes and competitors used are shown at the top.
Mutations are underlined. As control, lane 1 contains only g
32P-
labelled WT probe. LNK nuclear extract was incubated with labelled
WT probe at 48C for 20min (lane 2). For competition assays, unla-
belled competitors were incubated with LNK nuclear extract at 48C for
20min before addition of labelled WT probe for another 20-min incu-
bation. WT competitors were used at 10-, 25-, 50- and 100-fold molar
excess (lanes 3–6). Competitors with GABP, AP1 or both binding sites
mutated were used at 100-fold molar excess (lanes 7–9). Supershift
assays were carried out using 5mg of anti-GABPa (lane 10) or anti-
c-Jun (lane 11) antibodies.
Figure 3. Identiﬁcation of transcription factor binding sites that con-
tribute to Nkg2d-L regulation. (A) TESS search for transcription factor
binding sites in mB1. The sequence of the mB1 inserted in front of
mouse Nkg2d exon 1b is shown. Potential transcription factor binding
sites are indicated with brackets. Only mouse-speciﬁc, hematopoietic or
lymphocyte-related factors are shown. (B) Luciferase reporter assay of
truncated and mutated SINE elements. mB1 sequence was truncated at
the 50 and 30 ends or mutated at speciﬁc transcription factor binding
sites, cloned into pGL4B and assayed using a dual-luciferase system.
Mutated sites are indicated with an X. Promoter activities were normal-
ized to co-transfected Renilla luciferase activity and calculated as fold
above pGL4B. Data indicate mean ( SD) of two independent
experiments.
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Nkg2d-S and Nkg2d-L were assayed via real-time RT–
PCR. As shown in Figure 6, Gabp transcripts decreased
70% with Gabp siRNA. The negative control siRNA did
not decrease the expression of the three genes compared to
untreated samples. Gabp knockdown had no eﬀect on
Nkg2d-S levels but decreased the expression of Nkg2d-L
by 24% compared to the negative control. This suggests
that the mB1 associated Nkg2d-S, but not Nkg2d-L,i s
regulated at least in part by GABP.
PrevalenceofpotentialGABPsitesderivedfromB1elements
Neither the mB1 nor the rB1 GABP-binding sites are
present in the consensus sequences of 15 B1 subfamily
members found in RepBase, suggesting that these sites
were created through mutation after insertion. None-
theless, we wondered how many B1 elements in the
mouse genome contain such sites and if there is evidence
of these elements contributing to a regulatory network
as has been revealed recently for other repetitive elements
(see ‘Discussion’ section). A bioinformatics scan of all
potential GABP-binding motifs to see how many are
located in B1 elements is impractical since the core binding
sequence is short. We opted instead to compare the prev-
alence of GABP-site-containing B1 elements throughout
the genome and those near promoters. A survey of all
B1 elements (252832) in the mouse genome revealed that
4877 (1.93%) contain at least one GABP-binding site.
For the elements (70804) that lie in a 10kb window
centred around TSSs of all mouse RefSeq genes, we
found 1240 (1.75%) to have at least one GABP-binding
site. We then subjected these RefSeq genes to gene
ontology (GO) analysis using BiNGO (18). A comparison
of the genes with any B1 elements in the 10-kb window
to genes with GABP motif-associated B1 elements showed
no diﬀerences between these groups.
Mouse B1promoter activity isnot tissuespecific
Since GABP is a ubiquitous transcription factor, it likely
does not confer tissue speciﬁcity. To investigate this
issue, we tested a 30 truncated fragment of mB1 in
pGL4B using the EL4 and NIH 3T3 cell lines. EL4 is a
mouse T-lymphoblastoid cell line and NIH 3T3 is
a mouse embryonic ﬁbroblast cell line. Neither cell lines
express NKG2D (Figure 2B). The promoter activity of
this construct in EL4 is comparable to that of LNK
cells (Figure 7). The activity in NIH 3T3 is  3-fold
higher than in LNK and EL4 cells. This data demon-
strates that the promoter and enhancers within the
truncated mB1 retrotransposon are not tissue speciﬁc.
Figure 5. GABP forms protein–DNA complex within rB1 in EMSA. (A) DNA sequence alignment of mB1 and rB1. Identical bases are indicated by
vertical lines, and absent bases are shown as double dashes. Potential GABP-binding sites are labelled with brackets. (B) Sequences of probes and
competitors used are shown at the top. Mutations are underlined. As control, lane 1 contains only g
32P-labelled GABP1 and GABP2 WT probes.
RNK16 nuclear extract was incubated with labelled GABP1 and GABP2 WT probes at 48C for 20min (lanes 2 and 5). For competition assays,
unlabelled competitors were incubated with LNK nuclear extract at 48C for 20min before addition of labelled WT probe for another 20-min
incubation. WT competitors were used at 100-fold molar excess (lanes 3 and 6). Mutant competitors were also used at 100-fold molar excess (lanes 4
and 7). Supershift assays were carried out using 5mg of anti-GABPa (lanes 8 and 9) antibody.
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We wondered if the splicing pattern seen in rodents and
human correlated with divergence of splice signals.
Alignment of nine mammalian species at the intron1–
exon1b border shows the absence of splice acceptor signals
in rodents: mouse, rat and guinea pig (Figure 8A). It
is possible that the selection pressure to maintain this
splice signal was alleviated after the inserted SINE
became capable of initiating transcription of Nkg2d-L.
An added eﬀect is the emergence of Nkg2d-S, initiating
at exon 1a and skipping exon 1b now that the splice accep-
tor is eliminated. Interestingly, out of the nine mammals,
only mouse and rat have a SINE B1 element at this splice
junction. Thus, the evolution of guinea pig Nkg2d is
diﬀerent from the mouse and rat subclade. Furthermore,
we noted that guinea pig and cow were the only species
out of the nine examined that have lost the ATG1 start
codon (Figure 8B). Both retain the ATG2 start codon
while hedgehog does not (Figure 8C). This data shows
that the SINE is speciﬁc to a subclade of rodents, and
the splice acceptor signal at the intron1-exon1b junction
is not present in rodents.
DISCUSSION
In the present study, we show that the two splice forms
of mouse and rat Nkg2d arise from usage of alternative
promoters. The promoter for mouse and rat Nkg2d-L is a
SINE retrotransposon with a functional GABP-binding
site. Comparative genomics data suggest a complex evo-
lutionary model. Since guinea pigs lack the orthologous
SINE element, we believe the B1 inserted after the diver-
gence of guinea pig from the mouse and rat subclade. The
identiﬁed GABP-binding site in the mouse is not found
in the consensus B1 sequence, likely emerging through
mutation. This novel regulatory element may have
allowed the SINE to mediate transcription of the long
isoform of Nkg2d directly from exon 1b, lifting the selec-
tion pressure to maintain a splice acceptor signal at the
intron1–exon1b junction. The mutation of this splice
acceptor site forces the transcript starting from exon 1a
to splice directly to exon 2, thus creating NKG2D-S. The
mutation and its consequences on splicing we have just
described may apply to both mouse and rat. The only
diﬀerence between the two species is the position of the
acquired GABP-binding site. Thus, this study presents
an interesting example of convergent evolution to achieve
the same means in animals that share similar niches.
The 13 amino-acid diﬀerence at the N-terminus of the
two isoforms results in diﬀerential adapter aﬃnities:
NKG2D-L binds only DAP10 while NKG2D-S binds
both DAP10 and DAP12 (8). Signal cascades of these
two adapters are reviewed elsewhere (19). In essence,
DAP12-coupled Syk and ZAP70 signalling are strongly
stimulatory and initiate cytotoxic and cytokine release
pathways. On the other hand, DAP10 signalling
resembles co-stimulatory pathways of CD28 in T cells.
While DAP10 can initiate NK killing response through
Grb2/Vav1, it cannot trigger cytokine release. This
is shown in the inability of anti-NKG2D treated,
DAP12 knockout mouse NK cells to produce IFNg (9).
Malarkannan et al. (20) also showed that DAP12/Syk/
ZAP70-dependent activation of PLCg2 leading to the
Bcl10/NFkB pathway is absolutely essential to mouse
NK cytokine production. Diefenbach et al. reported that
while the long form of NKG2D is always expressed,
Figure 7. Detection of promoter activity in diﬀerent cell lines. A trun-
cated 77-bp mB1 sequence cloned into pGL4B was assayed using a
dual-luciferase system in LNK, EL4 and NIH 3T3 cells. Promoter
activity were normalized to co-transfected Renilla luciferase activity
and calculated as fold above pGL4B. Data indicate mean ( SD) of
at least two independent experiments.
Figure 6. Transient knockdown reveals requirement of GABP for full
expression of Nkg2d-S but not Nkg2d-L. LNK cells were treated with
GABPa or negative control Accell siRNA. Transcript levels of Gabp,
Nkg2d-S and Nkg2d-L were assayed by real-time RT–PCR and normal-
ized to the levels of Gapdh. mRNA levels from untreated cells (incu-
bated with carrier media but no siRNA) were set to one. Results are
the mean ( SD) of three independent experiments.  P=0.03 (Student’s
t-test).
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with IL-2 or polyinosinic:polycytidylic acid (8). Thus, it
is possible that the two diﬀerentially expressed, signalling
divergent splice forms provide the mouse and rat with
beneﬁcial functional ﬂexibility in a context-dependent
manner. In our model, we also believe that the losses of
ATG1 in guinea pig and in cow are separate events
of convergent evolution. The Nkg2d genes in these two
animals likely produce only the short protein form.
Indeed, Fikiri et al. (21) has reported the characterization
of a short NKG2D form in cow. Although the ﬂexibility
of signalling made possible to mouse and rat may not
be present in guinea pigs and cows, NKG2D in the
latter two can at least signal through DAP12 and may
therefore be beneﬁcial. Last, the loss of ATG1 in guinea
pigs may also have lifted selection pressure for retention
of the splice acceptor site, allowing it to mutate away.
Our results that repetitive elements aid in the regulation
of an NK receptor gene resonate with ﬁndings that link
an AluSx and a LINE L1M5 element to the regulation
of a human NK inhibitory receptor: KIR3DL1 (22). Of
particular interest is the fact that this AluSx SINE element
also contains a binding site for an ETS member, ELK1.
Removal of this SINE element abolished KIR3DL1
distal promoter activity. The enrichment of transposable
elements within immune genes has been noted before as
a possible mechanism of rapid evolution and functional
diversiﬁcation (23). Our ﬁndings ﬁt this model. While
an Alu element may have contributed to the evolution
of KIR3DL1 by supplying the gene with regulatory ele-
ments, a B1 has managed to both provide regulatory
signals and aid in the formation of a second, functionally
distinct isoform of NKG2D in mouse and rat.
Recent ChIP-sequencing studies have shown that some
classes of repetitive elements bind speciﬁc transcription
factors and establish transcription regulatory networks
on a genome-wide basis. Binding for the transcription
factor p53 was shown to be enriched in LTR10 and
MER61 elements of the endogenous retrovirus ERV1
family (24,25). Bourque et al. (25) further showed that
ESR1, POU5F1-SOX2 and CTCF-binding sites are per-
vasive in MIR, ERVK and B2 repeats, respectively.
Finally, Roman et al. (26) described a new subclass
of B1 element that harbours functional AhR and Slug-
binding sites. Thus some classes of transposable elements
are postulated to disperse speciﬁc control elements
and drive regulatory expansion. We therefore questioned
if B1 elements in the mouse genome may also be involved
in the regulatory network of GABP. Since only human
GABP ChIP-sequencing data is available (27) and B1
is a rodent-speciﬁc SINE element, we took an in silico
approach. Genomic distribution and GO analysis did
not reveal signs of selective retention of B1 elements
with GABP sites near promoters of any gene classes.
Thus, there is presently no evidence for this transposon
family acting as the foundation of GABP-regulatory net-
works. However, it is possible that other B1 elements
do bind GABP in vivo and could regulate genes. A
ChIP-sequencing experiment in mouse would be needed
to address this possibility directly.
B1 elements evolved from the 7SL RNA gene, a small
non-coding RNA species. As such, they are thought to be
transcribed through an internal polymerase III promoter
(28). The B1 element identiﬁed that regulates mouse and
rat Nkg2d represents a novel source of polymerase II pro-
moter signals. B2 elements, a close relative of B1 that
evolved from tRNA, have been found to provide a poly-
merase II promoter to the mouse gene lama3 (29). To our
knowledge, this is the ﬁrst instance that B1 elements are
shown to also contain polymerase II promoters.
Figure 8. Analysis of NKG2D splice signal and start codons. (A) DNA sequence alignment of nine mammalian species near the splice acceptor site of
human exon 2 using the human sequence as reference. Identical bases to the human reference are shown as dashes. Absent bases are shown as double
dashes. The 50 end of B1 sequences in mouse and rat are underlined. (B) DNA sequence alignment near the ATG start codon of human NKG2D
using the human sequence as reference. (C) DNA sequence alignment near the ATG2 start codon of mouse Nkg2d using the human sequence as
reference.
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decreases when the mB1 element is combined with 391bp
of upstream region. At least two non-mutually exclusive
explanations are possible. First, the 391-bp fragment may
contain an uncharacterized repressor. A search using TESS
locates multiple transcription factor-binding sites. It
remains to be seen if any of these are functional and bind
negative regulators. However, the promoter activity of a
construct containing mB1 decreases only slightly if the
391-bp fragment was inserted downstream of the reporter
gene. This suggests that any repressor present on the frag-
ment would be position dependent. The other possibility
is that of chromatin eﬀects. The reporter assays were
conducted using a transiently transfected plasmid. This
experimental system does not take into account the three-
dimensional conformations or the degree of histone pack-
aging of the DNA fragment in the context of the Nkg2d
gene. It is possible that the suppressive eﬀect of the 391-bp
segment is not seen in the endogenous context.
The mechanisms that underlie the increased promoter
activity with 30 truncated mB1 are also unclear. Again, it is
possible that the truncations removed repressor-binding
sites. At least four sites found via TESS in the truncated
regions bind transcription factors known to be both acti-
vating and repressing. Two sites can bind TCF1, a factor
that is activating when bound to b-catenin but repressive
when interacting with Groucho (30). YY1 is a repressor
when not interacting with E1A (31), while E12/E47 has
been shown to act as a repressor to E-cadherin (32).
Whether any of these sites are functional remains to be
shown. An additional possibility is the presence of an
ATG sequence that is removed in all 30 truncation con-
structs. Others have noted the possibility that ATG start
codons can compete with reporter gene start codon and
decrease reporter signal (33).
The ETS member GABP was ﬁrst implicated to regulate
a range of house-keeping genes such as ribosomal protein
genes and a cytochrome c oxidase gene (34–36). GABP
has also been linked to critical S-phase genes and cell-
cycle progression (37). Recently, a string of reports have
shown that GABP plays an important role in immune
functions. In the myeloid lineage, GABP is known to
regulate the genes for integrin CD18 as well as IgA Fc
receptor (38,39). The eﬀect of GABP in lymphocyte biol-
ogy is even more prominent. GABP was recently shown
to regulate Fc receptor g using monocyte, basophile and
T cell lines (40). In T cells, GABP bridges JNK/SAPK
signalling and enhanced IL-2 expression when artiﬁcially
stimulated (41). GABP is also known to enhance tran-
scription of Fas, IL-16 and IL7 receptor a (42–44). Last,
GABP deﬁciency leads to defective B cell development,
presumably because GABP binds to regulatory regions
of Pax5 and CD79a (45). In this report, we link GABP
directly to NK cells by showing its positive regulatory
eﬀects on mouse and rat Nkg2d.
ETS family members share highly similar binding sites.
In a genome wide study, Hollenhorst et al. (46) reported
widespread co-occupancy of GABP, ETS1 and
ELF1at promoters of human genes. We cannot rule out
the possibility that the binding site we discovered bind
these factors as well. GABP may compete with ETS1 or
ELF1 for binding while all three may act synergistically
to enhance Nkg2d-L transcription. This would reﬂect the
CD18 example, where GABP and PU.1 compete for
binding sites but cooperatively activate the gene (38).
Alternatively, these ETS members may not be competing
but rather forming a complex in mB1. Physical interaction
between the three GABP, ETS or ELF1 has not been
described, but GABP has been shown to bind two other
ETS members, ER71 and ER81 (47).
While EMSA experiments showed robust binding
of GABP to the B1 elements, knocking down Gabp
showed only a moderate decrease in Nkg2d-L transcript
levels. This could be due to an incomplete knockdown of
the transcription factor. We only achieved  70% silenc-
ing. The remaining GABP may be enough to sustain the
observed Nkg2d-L expression. Another possibility is
that GABP augments but is not absolutely required for
Nkg2d-L expression. Other transcription factors that
bind the B1 promoter may need to be silenced to see a
more dramatic decrease to Nkg2d-L mRNA levels.
Finally, similar ETS family binding motifs may allow
other ETS members to bind the B1 element and compen-
sate for the loss of GABP.
In mouse, NKG2D is known to be expressed only
on NK cells, activated CD8
+ T cells and some NKT
and gdT cells (48). The fact that the mB1 promoter
is capable of inducing reporter gene expression in NK,
T and embryonic ﬁbroblast cell lines leaves the question
of NKG2D tissue-speciﬁc expression open. This is per-
haps not surprising since GABP is a factor expressed
in a broad range of tissue (47). We can think of at least
two ways that speciﬁcity of Nkg2d-L expression can be
achieved. There could be additional enhancer sites that
bind tissue-speciﬁc transcription factors we have not
uncovered. Another possibility is epigenetic regulation
through DNA methylation and histone modiﬁcations.
Although the upstream regions of Nkg2d exons 1a and
1b are CpG poor, the expression of Ly49a, another NK
receptor gene, was shown to correlate with methylation
at a CpG poor promoter (49). The expression of other
NK receptor genes within the NK complex, Ly49g and
Nkg2a, have also been linked to CpG methylation or
histone acetylation (50,51). In addition, Santourlidis
et al. (52) suggests in a recent report that euchromatic
histone marks open up the KIR loci early in development
but use DNA methylation to silence speciﬁc KIR members
and establish clonal expression later on.
As more studies emerge, the diﬀerences between human
and mouse NK cells are starting to be appreciated. While
mouse NKG2D-L is the isoform that more closely
mimics human NKG2D, there are notable discrepancies.
NKG2D is expressed on human CD8
+ T cells regardless
of activation status in human, but only on activated
mouse CD8
+ T cells. The receptor is also found on gdT
cells of intestinal intraepithelial origin in human but
not mouse (48). Since human NKG2D does not harbour
a SINE element at the same position as the mouse,
the mode of regulation is unknown and likely diﬀerent
from mouse. Furthermore, nothing is known about the
regulation of the mouse short isoform, which responds
to IL-2 and polyinosinic:polycytidylic acid treatment (8).
Nucleic Acids Research,2009, Vol.37, No. 9 3041Dissecting the genomic and epigenetic factors that control
these processes have therapeutic potential since it may
allow the manipulation of an important NK-activating
receptor involved in cancer immunosurveillance, viral
clearance and autoimmune diseases.
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